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Abstract  Anastomotic  leakage  following  colorectal  surgery  is  a  serious,  fearful  and  the  most
important complication  mainly  after  anterior  resection  of  the  rectum  and  is  the  main  cause
of postoperative  morbidity  and  mortality.  Endo-SPONGE  (B-Braun  Medical®),  an  endoluminal
vacuum therapy  minimally  invasive,  was  shown  to  be  an  effective  alternative  in  the  treatment
of colorectal  anastomotic  leakage  with  local  infection  in  the  minor  pelvis.  A  case  of  endoscopic
closure  of  anastomotic  leakage  is  shown  after  anterior  resection  of  the  rectum  using  an  endo-
sponge and  the  role  of  this  new  device  in  the  treatment  of  anastomotic  leakage  is  discussed.
© 2012  Sociedade  Portuguesa  de  Gastrenterologia.  Published  by  Elsevier  España,  S.L.  All  rights
reserved.
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®
Deiscência  de  anastomose  após  cirurgia  colorectal  --  tratamento  com  Endo-SPONGE®
Resumo  A  deiscência  da  anastomose  colo-rectal  é  uma  complicac¸ão  séria  e  temida  após
ressecc¸ão anterior  do  recto,  sendo  a  principal  causa  de  morbilidade  e  mortalidade  pós-
operatória.  O  Endo-SPONGE  (B-Braun  Medical®),  terapia  de  vácuo  endoluminal  minimamente
invasiva,  mostrou  ser  uma  alternativa  efectiva  no  tratamento  da  deiscência  da  anastomose  colo-(B-Braun  Medical );
Terapia  de  vácuo
endoluminal
rectal com  infecc¸ão  local  na  pélvis  minor.  Apresenta-se  um  caso  de  encerramento  endoscópico
de deiscência  da  anastomose  colo-rectal,  após  ressecc¸ão  anterior  do  recto,  utilizando  o  Endo-
SPONGE® e  discute-se  qual  o  seu  papel  no  tratamento.
© 2012  Sociedade  Portuguesa  de  Gastrenterologia.  Publicado  por  Elsevier  España,  S.L.  Todos  os
direitos  reservados.∗ Corresponding author.
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Figure  2  Endoscopic  view  of  the  presacral  cavity  (depth:
6 ®
r
C
A
r
n
s
d
(
C
a
a
(
s
T
i
b
S
t
tEndo-SPONGE® treatment  for  anastomotic  leakage  after  col
Introduction
Anastomotic  leakage  following  colorectal  surgery  is  a seri-
ous,  fearful  and  the  most  important  complication  occurring
mainly  after  anterior  resection  of  the  rectum,  with  an  inci-
dence  ranging  from  1%  to  24%.1
It  is  associated  with  a  mortality  rate  between  6%  and
22%  and  is  found  mostly  in  patients  with  distal  rectal  anas-
tomoses  and  following  neoadjuvant  radiotherapy  and/or
chemotherapy.2
The  classical  treatment  for  these  patients,  if  the  peri-
tonitis  is  localized  to  the  minor  pelvis,  is  a  conservative  one
(broad-spectrum  antibiotic  coverage  and  transrectal  rins-
ing  and  drainage),  until  surgical  rescue  can  be  endeavored
(loop  colostomy  or  ﬁnally  abdominoperineal  extirpation)  if
the  sepsis  is  not  controlled.
However,  there  are  no  randomized  and  controlled  trials
in  the  literature  to  assess  the  best  treatment  and  currently
it  depends  on  the  extent  and  location  of  the  anastomotic
leakage  as  well  as  on  the  patient’s  comorbidities.
In  the  last  years,  Endo-SPONGE® (B.  Braun  Aesculap
AG,  Germany),  a  minimally  invasive  endoluminal  vacuum
therapy,  has  been  shown  to  be  an  effective  alternative  in
the  treatment  of  colorectal  anastomotic  leakage  with  local
infection  in  the  minor  pelvis.3--6
The  Endo-SPONGE® is  an  open-pored  polyurethane
sponge  with  7  cm  in  length  and  3  cm  in  diameter  that  is
cut  according  to  the  size  of  the  wound  cavity  and  placed
transanally  after  diagnostic  examination  with  a  ﬂexible  gas-
troscope.  Depending  on  the  size  of  the  cavity  one  or  more
sponges  can  be  placed.  An  overtube  and  endoscope  are
inserted  into  the  deepest  point  of  the  wound  cavity.  After
removing  the  gastroscope  the  lubricated  Endo-SPONGE® is
placed  through  the  overtube  by  using  a  pushing  probe.  The
position  of  the  sponges  can  be  adjusted  endoscopically.  The
sponge  is  subsequently  connected  to  a  low  vacuum  suc-
tion  bottle  (Redyrob  Trans  Plus®,  B.  Braun  Aesculap  AG,
Germany)  that  is  ﬁxed  to  the  skin  of  the  buttock  with  adhe-
sive  tape.  The  Endo-SPONGE® allows  continuous  drainage,
debridement  and  rapid  cleaning  of  the  presacral  cavity,  pro-
moting  the  formation  of  granulation  tissue,  decreasing  the
size  of  cavity  and  healing  of  the  presacral  abscess.
We  report  a  case  of  anastomotic  leakage  after  anterior
resection  of  the  rectum  which  was  successfully  treated  with
Endo-SPONGE®.
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Figure  1  Discontinuity  of  the  rectal  wall  at  the  anasto
(7.5 cm  ×  5.4  cm  ×  6.2  cm). cm)  before  Endo-SPONGE treatment,  at  the  site  of  the  colo-
ectal  anastomosis.
ase report
 40-year-old  man  diagnosed  with  stage  II  (T3N1M0)
ectal  adenocarcinoma  in  April  2009  was  submitted  to
eoadjuvant  chemoradiotherapy  before  a low  anterior
phincter-preserving  rectal  resection  in  August  2009.  Eight
ays  after  the  procedure,  the  patient  developed  fever
38.5 ◦C)  and  rectal  bleeding.  At  this  time  a  diagnostic
T  scan  of  the  abdomen  and  pelvis  with  intravenously
dministered  contrast  media  was  ordered  and  it  revealed
n  anastomotic  leakage  with  a  large  presacral  abscess
7.5  cm  ×  5.4  cm  ×  6.2  cm)  (Fig.  1).
He  was  treated  on  broad-spectrum  antibiotics  and  tran-
rectal  rinsing  and  drainage  without  clinical  improvement.
hirty-three  days  after  the  initial  surgery,  a  diverting  loop
leostomy  (double-barrel)  was  performed  and  on  day  53  he
egan  endoluminal  vacuum  therapy.  Endoscopy  before  Endo-
PONGE® treatment  showed  anastomotic  leakage  of  180◦ of
he  internal  circumference,  10  cm  above  the  anal  verge  with
he  presacral  cavity  measuring  6  cm  at  the  deepest  point  of
he  cavity  (Fig.  2).Endo-SPONGE® treatment  was  performed  under  mild
edation  (midazolam  1  mg  plus  meperidine  25  mg)  and
sing  a  small-caliber  ﬂexible  gastroscope  (GIF-145  Video
motic  site  and  an  associated  large  presacral  abscess
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Figure  3  Healing  of  the  wound  cavity.
Gastroscope,  Olympus,  9.8  mm  diameter).  After  the  initial
two  sessions  the  patient  was  discharged  with  the  following
procedures  being  conducted  on  an  outpatient  basis.
During  the  treatment  sessions  as  the  cavity  reduced  in
size,  being  ﬁlled  with  granulation  tissue,  the  size  of  the
sponge  used  was  also  reduced  to  a  length  of  0.8  cm  in
the  last  session  (Fig.  3).
Every  two  days  a  session  was  performed,  except  on  week-
ends,  with  the  sponges  being  exchanged  to  prevent  the
growth  of  granulation  tissue  into  them  and  to  reduce  painful
sponge  exchanges.
Thirty-four  sponge  exchanges  were  executed  with  a
median  number  of  ‘‘sponges  per  session’’  of  two,  ranging
from  one  to  three,  without  any  particular  complication
(occasional  bleeding  in  presacral  cavity).  The  resolution  of
the  wound  cavity  was  achieved  75  days  after  the  beginning
of  the  treatment  (Fig.  4).
In  follow-up,  60  days  after  the  end  of  treatment,  a  MRI
scan  (Fig.  5)  showed  only  an  organized  ﬁbrous  tissue  collec-
tion  (1.2  cm  ×  1.4  cm)  without  any  evidence  of  abscess  or
ﬁstula.
Diverting  loop  ileostomy  could  be  closed  341  days  after
the  beginning  of  the  treatment,  without  complications.
Figure  4  Resolution  of  the  wound  cavity.
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aigure  5  Organized  ﬁbrous  tissue  collection  at  the  end  of
reatment  --  1.2  cm  ×  1.4  cm  (MRI  scan).
urrently  the  patient  is  asymptomatic  with  regular  bowel
ovements.
iscussion
acuum-assisted  closure  therapy  has  been  applied  in
urgery,  for  several  years  for  complicated  wounds  (com-
lex  diabetic  foot  wounds,  traumatic  wounds,  postoperative
nfected  wounds)  with  good  outcomes.  Its  beneﬁcial  effect
n  wound  healing  is  related  with  an  increase  of  blood  ﬂow,
timulation  of  granulation  tissue  formation  and  decrease
f  bacterial  contamination.7,8 Recently  Endo-SPONGE®,  an
ndoluminal  vacuum  therapy,  was  introduced  alike  as  a
ethod  for  the  treatment  of  anastomotic  leakage  after  colo-
ectal  surgery,  allowing  continuous  drainage,  debridement
nd  rapid  cleaning  of  the  wound  cavity.  It  was  shown  to  be
n  effective  alternative  in  the  treatment  of  colorectal  ana-
tomotic  leakage  with  local  infection  in  the  minor  pelvis.3--6
The  main  goal  of  any  therapeutics  for  anastomotic  leak-
ge  will  be  to  close  and  drain  the  presacral  cavity  in  the
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shortest  period  of  time,  since  the  prolonged  pelvic  sep-
sis  and  ﬁbrosis  are  related  with  functional  outcome  after
ileostomy  closure.9 Continuous  and  effective  drainage  of
the  wound  cavity  plays  a  major  role  in  the  ﬁnal  outcome
and  it  is  ensured  by  the  Endo-SPONGE® either  by  the  nega-
tive  pressure  drainage  system  that  bypasses  the  physiologic
anal  sphincter  tonus  or  by  the  barrier  effect  that  avoids
permanent  contact  of  infected  secretions  and  gas  with  the
perirectal  tissue  in  the  minor  pelvis.
In  2008  Weidenhagen  et  al.4 described  a  series  of
29  patients  of  which  28  (97%)  achieved  deﬁnitive  closure
in  a  median  of  34  (range  4--79)  days.  One  year  later  Von
Bernstorff  et  al.10 showed  closure  of  the  presacral  cavity
in  23  of  26  patients  (88.5%)  with  an  average  duration  of
49.9  (range  10--221)  days.  Van  Koperen  et  al.6 found  infe-
rior  results  with  regard  to  the  closure  of  the  cavity  (56%)  in
a  series  of  16  patients,  which  could  be  related  to  late  onset
usage  of  Endo-SPONGE®.
In  our  patient  the  number  of  days  required  until  res-
olution  of  the  cavity  can  be  explained  by  three  factors:
the  late  onset  of  the  vacuum  therapy  (number  of  days
elapsed  between  the  beginning  of  the  therapeutic  and  colo-
rectal  surgery),  the  fact  that  the  patient  was  submitted  to
neoadjuvant  chemoradiotherapy  and  ﬁnally  the  size  of  the
presacral  abscess.
Van  Koperen  et  al.6 showed  that  patients  who  promptly
started  Endo-SPONGE  after  colorectal  surgery  (<6  weeks),
had  higher  closure  rates  of  the  presacral  cavity  than  patients
who  started  later  (>6  weeks).  On  the  other  hand  Von
Bernstorff  et  al.10 demonstrated  that  patients  who  started
endo-sponge  following  neoadjuvant  treatment  had  signif-
icantly  longer  time  (days)  until  closure  of  the  presacral
cavity,  more  sponge  exchanges  and  larger  cavities.
In  the  case  that  we  report,  the  patient  was  submit-
ted  to  a  diverting  loop  ileostomy  (double-barrel)  with  the
aim  of  making  fecal  diversion  to  keep  the  wound  clean
and  promote  a  faster  healing.  But  was  it  really  necessary?
The  Endo-SPONGE® is  a  vacuum-assisted  closure  therapy
that  obturates  totally  the  presacral  cavity  preventing  the
communication  of  the  sinus  with  fecal  content.  Weiden-
hagen  et  al.4 treated  successfully  ﬁve  patients  without
performing  a  diverting  stoma,  requiring  only  in  one  case
the  creation  of  a  stoma  for  infection  control.  Randomized
controlled  studies  will  be  needed  in  this  area.
Endo-SPONGE® placement  can  be  helpful  in  the  treat-
ment  of  anastomotic  leakage  after  colorectal  surgery  andtal  surgery  135
ay  prevent  chronic  presacral  sinus  and  avoid  deﬁnitive
olostomy.
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